These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39135136)

  • 1. Genomic profiles and clinical presentation of chordoma.
    Koka H; Zhou W; McMaster ML; Bai J; Luo W; Klein A; Zhang T; Hua X; Li X; Wang D; Xiong Y; Jones K; Vogt A; Hicks B; Parry D; Goldstein AM; Yang XR
    Acta Neuropathol Commun; 2024 Aug; 12(1):129. PubMed ID: 39135136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.
    Parry DM; McMaster ML; Liebsch NJ; Patronas NJ; Quezado MM; Zametkin D; Yang XR; Goldstein AM
    J Neurosurg; 2021 May; 134(5):1399-1408. PubMed ID: 32559743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
    Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
    Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival.
    Bai J; Shi J; Li C; Wang S; Zhang T; Hua X; Zhu B; Koka H; Wu HH; Song L; Wang D; Wang M; Zhou W; Ballew BJ; Zhu B; Hicks B; Mirabello L; Parry DM; Zhai Y; Li M; Du J; Wang J; Zhang S; Liu Q; Zhao P; Gui S; Goldstein AM; Zhang Y; Yang XR
    Nat Commun; 2021 Feb; 12(1):757. PubMed ID: 33536423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
    Passeri T; Gutman T; Hamza A; Adle-Biassette H; Girard E; Beaurepere R; Tariq Z; Mariani O; Dahmani A; Bourneix C; Abbritti R; Driouch K; Bohec M; Servant N; Baulande S; Decaudin D; Guichard JP; Calugaru V; Feuvret L; Guinebretière JM; Champion L; Bièche I; Froelich S; Mammar H; Masliah-Planchon J
    J Neurosurg; 2023 Nov; 139(5):1270-1280. PubMed ID: 37029667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The brachyury Gly177Asp SNP is not associated with a risk of skull base chordoma in the Chinese population.
    Wu Z; Wang K; Wang L; Feng J; Hao S; Tian K; Zhang L; Jia G; Wan H; Zhang J
    Int J Mol Sci; 2013 Oct; 14(11):21258-65. PubMed ID: 24232574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma.
    Kelley MJ; Shi J; Ballew B; Hyland PL; Li WQ; Rotunno M; Alcorta DA; Liebsch NJ; Mitchell J; Bass S; Roberson D; Boland J; Cullen M; He J; Burdette L; Yeager M; Chanock SJ; Parry DM; Goldstein AM; Yang XR
    Hum Genet; 2014 Oct; 133(10):1289-97. PubMed ID: 24990759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and transcriptomic characterization of skull base chordoma.
    Sa JK; Lee IH; Hong SD; Kong DS; Nam DH
    Oncotarget; 2017 Jan; 8(1):1321-1328. PubMed ID: 27901492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The driver landscape of sporadic chordoma.
    Tarpey PS; Behjati S; Young MD; Martincorena I; Alexandrov LB; Farndon SJ; Guzzo C; Hardy C; Latimer C; Butler AP; Teague JW; Shlien A; Futreal PA; Shah S; Bashashati A; Jamshidi F; Nielsen TO; Huntsman D; Baumhoer D; Brandner S; Wunder J; Dickson B; Cogswell P; Sommer J; Phillips JJ; Amary MF; Tirabosco R; Pillay N; Yip S; Stratton MR; Flanagan AM; Campbell PJ
    Nat Commun; 2017 Oct; 8(1):890. PubMed ID: 29026114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.
    Gill CM; Fowkes M; Shrivastava RK
    Neurosurgery; 2020 Feb; 86(2):E118-E123. PubMed ID: 31504814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma.
    Zhu GG; Ramirez D; Chen W; Lu C; Wang L; Frosina D; Jungbluth A; Ntiamoah P; Nafa K; Boland PJ; Hameed MR
    Hum Pathol; 2020 Oct; 104():73-83. PubMed ID: 32795465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.
    Bettegowda C; Yip S; Lo SL; Fisher CG; Boriani S; Rhines LD; Wang JY; Lazary A; Gambarotti M; Wang WL; Luzzati A; Dekutoski MB; Bilsky MH; Chou D; Fehlings MG; McCarthy EF; Quraishi NA; Reynolds JJ; Sciubba DM; Williams RP; Wolinsky JP; Zadnik PL; Zhang M; Germscheid NM; Kalampoki V; Varga PP; Gokaslan ZL;
    Neuro Oncol; 2017 Mar; 19(3):405-413. PubMed ID: 27663388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T gene isoform expression pattern is significantly different between chordomas and notochords.
    Wang K; Hu Q; Wang L; Chen W; Tian K; Cao C; Wu Z; Jia G; Zhang L; Zeng C; Zhang J
    Biochem Biophys Res Commun; 2015 Nov; 467(2):261-7. PubMed ID: 26435504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: A case report.
    Curcio C; Cimera R; Aryeequaye R; Rao M; Fabbri N; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Jan; 60(1):43-48. PubMed ID: 32920865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between TBXT rs2305089 polymorphism and chordoma in Iranian patients identified by a developed T-ARMS-PCR assay.
    Jalessi M; Gholami MS; Razmara E; Hassanzadeh S; Sadeghipour A; Jahanbakhshi A; Tabibkhooei A; Bahrami E; Falah M
    J Clin Lab Anal; 2022 Jan; 36(1):e24150. PubMed ID: 34837714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
    Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes.
    Bai J; Shi J; Zhang Y; Li C; Xiong Y; Koka H; Wang D; Zhang T; Song L; Luo W; Zhu B; Hicks B; Hutchinson A; Kirk E; Troester MA; Li M; Shen Y; Ma T; Wang J; Liu X; Wang S; Gui S; McMaster ML; Chanock SJ; Parry DM; Goldstein AM; Yang XR
    Clin Cancer Res; 2023 Jan; 29(1):261-270. PubMed ID: 36260525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First cytogenetic study of a recurrent familial chordoma of the clivus.
    Dalprà L; Malgara R; Miozzo M; Riva P; Volonte M; Larizza L; Fuhrman Conti AM
    Int J Cancer; 1999 Mar; 81(1):24-30. PubMed ID: 10077147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis.
    Diaz RJ; Guduk M; Romagnuolo R; Smith CA; Northcott P; Shih D; Berisha F; Flanagan A; Munoz DG; Cusimano MD; Pamir MN; Rutka JT
    Neoplasia; 2012 Sep; 14(9):788-98. PubMed ID: 23019410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.